Search Results - "Schur, S"

Informal caregivers of advanced-stage cancer patients: Every second is at risk for psychiatric morbidity by Rumpold, T., Schur, S., Amering, M., Kirchheiner, K., Masel, E. K., Watzke, H., Schrank, B.

“…Purpose Informal caregivers of advanced cancer patients are known to suffer from high distress due to their caregiving responsibilities. Nevertheless, a…”
Get full text

Pulmonary metastasectomy for soft tissue sarcoma – Report from a dual institution experience at the Medical University of Vienna by Schur, S, Hoetzenecker, K, Lamm, W, Koestler, W.J, Lang, G, Amann, G, Funovics, P, Nemecek, E, Noebauer, I, Windhager, R, Klepetko, W, Brodowicz, T

“…Abstract Background Pulmonary metastasectomy when possible has become therapeutic standard in soft tissue sarcoma patients. However, published reports…”
Get full text

Hope as determinant for psychiatric morbidity in family caregivers of advanced cancer patients by Rumpold, T., Schur, S., Amering, M., Ebert‐Vogel, A., Kirchheiner, K., Masel, E., Watzke, H., Schrank, B.

“…Objective Home care of advanced cancer patients often has adverse effects on physical and mental health of family caregivers. Little is known about the…”
Get full text

Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patients by Masel, E.K., Berghoff, A.S., Füreder, L.M., Heicappell, P., Schlieter, F., Widhalm, G., Gatterbauer, B., Dieckmann, U., Birner, P., Bartsch, R., Schur, S., Watzke, H.H., Zielinski, C.C., Preusser, M.

“…Body mass index (BMI) is a prognostic factor in several cancer types. We investigated the prognostic role of BMI in a large patient cohort with newly diagnosed…”
Get full text

The PERS2ON score for systemic assessment of symptomatology in palliative care: a pilot study by Masel, E.K., Berghoff, A.S., Schur, S., Maehr, B., Schrank, B., Simanek, R., Preusser, M., Marosi, C., Watzke, H.H.

“…The comprehensive assessment of symptoms is the basis for effective, individualised palliative treatment. Established scoring systems provide in‐depth…”
Get full text

The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS) by Ploner, F., Lamm, W., Schur, S., Eisterer, W., Kühr, T., Lindorfer, A., Tinchon, C., Köstler, W. J., Szkandera, J., Brodowicz, T.

“…Purpose The purpose of this retrospective analysis was to assess efficacy and tolerability of trabectedin in soft tissue sarcoma (STS) in the routine clinical…”
Get full text

AS11-01 - Distress and hope in caring for terminally ill cancer patients by Schur, S, Ebert-Vogel, A, Watzke, H, Schrank, B

“…Introduction Cancer is a leading cause of death world-wide. Many patients spend the end of their lives at home while being cared for by family members…”
Get full text

Clinical signs of neurofibromatosis impact on the outcome of malignant peripheral nerve sheath tumors by Lamm, W, Schur, S, Köstler, W J, Funovics, P, Windhager, R, Amann, G, Panotopoulos, J, Pokrajac, B, Brodowicz, T

“…Malignant peripheral nerve sheath tumors (MPNST) are a rare subtype of sarcoma, with a poor outcome. MPNST are regarded as being sporadic or associated with…”
Get more information

Sarcoma of the Ewing Family in Pregnancy: A Case Report of Intrauterine Fetal Death after Induction of Chemotherapy by Schur, S., Wild, J., Amann, G., Köstler, W., Langer, M., Brodowicz, T.

“…Ewing’s sarcoma is an ultra-orphan disease (2/1,000,000/year) which requires a multimodal therapy approach in high-volume centers. Treatment consists of…”
Get full text

Mixed-lineage eosinophil/basophil crisis in MDS: a rare form of progression by Wimazal, F., Baumgartner, C., Sonneck, K., Zauner, C., Geissler, P., Schur, S., Samorapoompichit, P., Müllauer, L., Födinger, M., Agis, H., Sperr, W. R., Valent, P.

“…ABSTRACT Background   Basophilic crisis and eosinophilia are well recognized features of advanced chronic myeloid leukaemia. In other myeloid neoplasms,…”
Get full text

Occupational and Environmental Associations with Antinuclear Antibodies in a General Population Sample by Cooper, Glinda S., Parks, Christine G., Schur, Peter S., Fraser, Patricia A.

“…Antinuclear antibodies are a hallmark feature of the autoimmune disease systemic lupus erythematosus, and can occur many years before onset of symptoms. The…”
Get full text

"Real world" atypical antipsychotic prescribing practices in public child and adolescent inpatient settings by Pappadopulos, Elizabeth, Jensen, Peter S, Schur, Sarah B, MacIntyre, 2nd, James C, Ketner, Scott, Van Orden, Kimberly, Sverd, Jeffrey, Sardana, Sadhana, Woodlock, David, Schweitzer, Robert, Rube, David

“…This article examines the factors that influence antipsychotic use among youth treated in public inpatient facilities. By combining data from 11 focus groups,…”
Get full text

165MO Trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients (pts) with active brain metastases: Primary outcome analysis from the TUXEDO-1 trial by Bartsch, R., Berghoff, A.S., Furtner, J., Marhold, M., Bergen, E.S., Roider-Schur, S., Starzer, A.M., Forstner, H., Rottenmanner, B., Dieckmann, K., Bago-Horvath, Z.A., Widhalm, G., Ilhan-Mutlu, A., Minichsdorfer, C., Fuereder, T., Singer, C.F., Weltermann, A., Puhr, R., Preusser, M.

Get full text

280P Intracranial activity of trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients with active brain metastases: Results from the first stage of the phase II TUXEDO-1 trial by Bartsch, R., Berghoff, A.S., Furtner, J., Bergen, E.S., Roider-Schur, S., Marhold, M., Starzer, A.M., Forstner, H., Rottenmanner, B., Dieckmann, K., Bago-Horvath, Z.A., Widhalm, G., Ilhan-Mutlu, A., Minichsdorfer, C., Fuereder, T., Singer, C.F., Weltermann, A., Preusser, M.

Get full text

Pembrolizumab (PEM) in patients with advanced/metastatic bone sarcoma (BS) or soft tissue sarcoma (STS): Named patient use by the Medical University of Vienna by Schur, S., Brodowicz, T., Gad, B., Hamacher, R., Amann, G., Lang, S.

Get full text

P15.01 Anti-Ri syndrome presenting with bilateral CN VI palsy and jaw dystonia by Freydl, E., Thier, K., Schur, S., Oberndorfer, S.

“…Paraneoplastic neurological syndromes are rare disorders associated by various onconeuronal antibodies, which usually precede tumor diagnosis. Anti-RI…”
Get full text

281MO Quality of life and neurocognitive function in patients with active brain metastases of HER2-positive breast cancer treated with trastuzumab-deruxtecan: Secondary endpoint analysis of the prospective single-arm phase II TUXEDO-1 trial by Starzer, A.M., Berghoff, A.S.S., Furtner, J., Marhold, M., Bergen, E.S., Roider-Schur, S., Forstner, H., Rottenmanner, B., Dieckmann, K., Bago-Horvath, Z., Widhalm, G., Ilhan-Mutlu, A., Minichsdorfer, C., Fuereder, T., Gruenberger, B., Singer, C., Weltermann, A., R. Puhr, Preusser, M., Bartsch, R.

Get full text

1348PA NATIONWIDE SURVEY ON PALLIATIVE SEDATION FOR TERMINALLY ILL CANCER PATIENTS BY THE AUSTRIAN PALLIATIVE CARE (AUPAC) STUDY GROUP by Schur, S., Masel, E.K., Mayrhofer, M., Watzke, H.H.

“…Abstract Aim: Palliative sedation (PS) is defined as the controlled use of sedative drugs to alleviate unbearable suffering caused by refractory symptoms…”
Get full text

A Nationwide Survey on Palliative Sedation for Terminally Ill Cancer Patients By the Austrian Palliative Care (Aupac) Study Group by Schur, S., Masel, E.K., Mayrhofer, M., Watzke, H.H.

Get full text

OS01.5.A Neuron-specific enolase (NSE) and S100 serum levels in patients with active brain metastases from HER2-positive breast cancer treated with trastuzumab-deruxtecan (T-DXd): A biomarker analysis from the TUXEDO-1 trial by Berghoff, A S, Bartsch, R, Furtner, J, Marhold, M, Bergen, E S, Roider-Schur, S, Starzer, A M, Forstner, H, Rottenmanner, B, Dieckmann, K, Bago-Horvath, Z, Widhalm, G, Ilhan-Mutlu, A, Minichsdorfer, C, Fuereder, T, Singer, C F, Weltermann, A, Haslacher, H, Szekeres, T, Puhr, R, Preusser, M

“…Abstract Background T-DXd is a novel antibody-drug conjugate with high activity in HER2-positive metastatic breast cancer. The prospective, single-arm,…”
Get full text